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Abstract
Angiogenesis crucially contributes to various diseases, such as cancer and diabetic retinopathy. Hence, anti-angiogenic 
therapy is considered as a powerful strategy against these diseases. Previous studies reported that the acyclic monoterpene 
linalool exhibits anticancer, anti-inflammatory and anti-oxidative activity. However, the effects of linalool on angiogenesis 
still remain elusive. Therefore, we investigated the action of (3R)-(−)-linalool, a main enantiomer of linalool, on the angio-
genic activity of human dermal microvascular endothelial cells (HDMECs) by a panel of angiogenesis assays. Non-cytotoxic 
doses of linalool significantly inhibited HDMEC proliferation, migration, tube formation and spheroid sprouting. Linalool 
also suppressed the vascular sprouting from rat aortic rings. In addition, Matrigel plugs containing linalool exhibited a 
significantly reduced microvessel density 7 days after implantation into BALB/c mice. Mechanistic analyses revealed that 
linalool promotes the phosphorylation of extracellular signal-regulated kinase (ERK), downregulates the intracellular level 
of adenosine triphosphate (ATP) and activates the transient receptor potential cation channel subfamily M (melastatin) 
member (TRPM)8 in HDMECs. Inhibition of ERK signaling, supplementation of ATP and blockade of TRPM8 signifi-
cantly counteracted linalool-suppressed HDMEC spheroid sprouting. Moreover, ATP supplementation completely reversed 
linalool-induced ERK phosphorylation. In addition, linalool-induced ERK phosphorylation inhibited the expression of bone 
morphogenetic protein (BMP)-2 and linalool-induced TRPM8 activation caused the inhibition of β1 integrin/focal adhesion 
kinase (FAK) signaling. These findings indicate an anti-angiogenic effect of linalool, which is mediated by downregulating 
intracellular ATP levels and activating TRPM8.
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Introduction
Angiogenesis is a highly dynamic process, which is defined 
as the development of new blood vessels from preexisting 
ones. During this process, endothelial cells (ECs) are acti-
vated by pro-angiogenic factors, such as vascular endothe-
lial growth factor (VEGF) and basic fibroblast growth factor 
(bFGF), to proliferate, migrate and form new microvascu-
lar networks [1]. These activities of ECs are mediated by 
several pivotal angiogenesis-related pathways, including 
phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian tar-
get of rapamycin (mTOR) and Raf/mitogen-activated protein 
kinase (MEK)/extracellular signal-regulated kinase (ERK) 
signaling [2, 3]. Notably, ERK has also been reported to be 
activated by different stress stimuli, such as oxidative stress 
and DNA damage stimuli, and suppress cell proliferation 
and survival [4–7].
Recently, Genova et al. demonstrated an inhibitory effect 
of transient receptor potential cation channel subfamily M 
(melastatin) member 8 (TRPM8) on EC adhesion, migra-
tion, tube formation and spheroid sprouting [8]. TRPM8, 
also known as the cold and menthol receptor 1 (CMR1), is 
the main molecular transducer of cold somatosensation in 
humans. It can be activated by voltage, cold temperatures 
and cooling compounds, such as menthol and icilin [9–11]. 
Upon activation, sodium and calcium ions pass through 
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TRPM8 channels into cells to regulate various cellular pro-
cesses [12]. Of interest, Genova et al. reported that TRPM8 
inhibits EC motility independently of pore function, but 
retains Rap1 GTPase through direct protein-protein inter-
action [8].
Angiogenesis occurs during embryogenesis and wound 
healing. On the other hand, the development of new blood 
vessels is critically involved in a large number of diseases, 
including cancer, endometriosis, psoriasis and diabetic retin-
opathy [13]. Accordingly, the inhibition of angiogenesis 
represents a promising strategy for the treatment of these 
diseases. So far, the United States Food and Drug Adminis-
tration has approved several anti-angiogenic agents target-
ing the VEGF/VEGF receptor pathway [14]. Unfortunately, 
these agents are quite expensive and frequently induce 
severe side effects during long-term treatment. Therefore, 
there is an urgent need for the development of novel anti-
angiogenic drugs with fewer side effects.
  Phytochemicals are considered as a rich source for the 
discovery of new compounds, which are cheap, effective and 
safe. Such a compound is linalool, a main active ingredi-
ent of essential oils of various aromatic species, including 
lavender, orange and rose. Actually, linalool is produced by 
over 200 different plant species and also found in some fungi 
[15]. It is widely used as a fragrance ingredient in shampoos, 
body lotions, perfume and soaps. Moreover, it is also com-
monly used as a flavoring in beverages and foods [15]. Previ-
ous studies reported a broad spectrum of biological activi-
ties for linalool, including sedative, analgesic, anticancer, 
antioxidant, antimicrobial and anti-inflammatory properties 
[16, 17]. However, so far nothing is known about its effects 
on angiogenesis.
Therefore, the aim of the present study was to investigate 
the action of (3R)-(−)-linalool on the proliferation, migra-
tion, tube formation and spheroid sprouting of human dermal 
microvascular endothelial cells (HDMECs). To validate our 
in vitro findings, we additionally performed an ex vivo aortic 
ring assay and an in vivo Matrigel plug assay. Moreover, 
we analyzed the effects of linalool on angiogenesis-related 
signaling pathways, intracellular levels of adenosine triphos-
phate (ATP), reactive oxygen species (ROS) formation and 
TRPM8 activity in HDMECs. In addition, the downstream 
anti-angiogenic mediators of linalool-induced ATP reduc-
tion and TRPM8 activation were identified.
Materials and methods
Cell culture and treatment
HDMECs (PromoCell, Heidelberg, Germany) were cul-
tured in endothelial cell growth medium (EGM)-MV (Pro-
moCell) and incubated at 37 °C in a humidified atmosphere 
containing 5%  CO2. A stock solution of 5 M (3R)-(−)-
linalool (Sigma-Aldrich, Darmstadt, Germany) was pre-
pared in dimethyl sulfoxide (DMSO) and further diluted 
into different concentrations (0.05–5 mM) in EGM-MV. The 
DMSO concentrations were identical in the linalool- and 
vehicle-treated groups. The cells were exposed to linalool 
for 24 h followed by different in vitro assays.
Cell transfection
To downregulate the expression level of ERK and TRPM8, 
HDMECs were transfected for 48  h with 20 nM small 
interfering RNAs (siRNAs) against ERK1/2 (si-ERK; Cell 
Signaling Technology, Frankfurt, Germany) or 120 nM siR-
NAs against TRPM8 (si-TRPM8; ON-TARGETplus siRNA 
SMARTpool, Dharmacon, Colorado, USA) using HiPerFect 
reagent (Qiagen, Hilden, Germany) according to the manu-
facturer’s protocol. Negative control of siRNA (si-NC, Qia-
gen) served as control.
Water‐soluble tetrazolium (WST)‑1 assay
Cell viability was assessed by a WST-1 assay, in which 
tetrazolium salt is converted into soluble formazan by mito-
chondrial dehydrogenase. The amount of produced formazan 
depends on the number of viable cells. As described previ-
ously [18], 5 ×  103 HDMECs were seeded in each well of 
96-well plates and exposed to different compounds for 24 h. 
Then, 10 µL WST-1 reagent (Roche Diagnostics, Mannheim, 
Germany) was added into each well and the plate was incu-
bated at 37 °C for 30 min. The absorbance of each well was 
measured at 450 nm with 620 nm as reference using a micro-
plate photometer (PHOmo; anthos Mikrosysteme GmbH, 
Krefeld, Germany).
Lactate dehydrogenase (LDH) assay
The cytotoxicity of linalool was analyzed by a LDH assay 
according to the manufacturer’s instructions (Roche Diag-
nostics). Briefly, 5 ×  103 HDMECs were seeded in each well 
of 96-well plates and exposed for 24 h to different concen-
trations of linalool. Then, 100 µL LDH reaction mix was 
added into each well. After 10 min of incubation at room 
temperature, the reaction was stopped by addition of 50 µL 
stop solution. The absorbance of each well was then meas-
ured at 492 nm with 620 nm as reference using a microplate 
photometer (PHOmo).
Flow cytometry
The effects of linalool on EC proliferation, ROS formation 




To assess cell proliferation, a bromodeoxyuridine (BrdU) 
assay was performed. Briefly, HDMECs seeded in 60-mm 
dishes were exposed to different concentrations of linalool 
for 6 h followed by BrdU addition and incubation for another 
18 h. Then, the cells were fixed with 70% ethanol for 30 min 
on ice and incubated with 2 M hydrochloric acid (HCl) con-
taining 0.5% Triton-X 100 for 30 min at room temperature 
for DNA denaturation. After incubation with a fluorescein 
isothiocyanate (FITC)-labeled anti-BrdU antibody (1:50; 
Thermo Fisher Scientific, Karlsruhe, Germany) for 30 min, 
the cells were measured with a FACScan flow cytometer 
(BD Biosciences, Heidelberg, Germany).
Intracellular ROS levels were measured with 
2′,7′-dichloro-dihydro-fluorescein diacetate (DCFH-DA). 
Briefly, 3 ×  105 HDMECs seeded in 6-well plates were 
pretreated for 2 h with 0.5 mM reducing agent dithiothrei-
tol (DTT) and then exposed for 24 h to 0 or 2 mM linal-
ool. Then, the cells were incubated with 0.5 µM DCFH-
DA (Sigma-Aldrich) at 37 °C for 30 min. Alternatively, 
HDMECs were pretreated for 2 h with 0.5 mM DTT, incu-
bated for 30 min with 0.5 µM DCFH-DA and then treated 
for 30 min with 0.5 mM  H2O2. After collecting the cells with 
a scraper, the intracellular fluorescence intensity was then 
measured by a FACScan flow cytometer (BD Biosciences). 
 H2O2-treated cells served as a positive control for ROS 
generation.
To evaluate the activation of β1 integrin, 3 ×  105 
HDMECs seeded in 6-well plates were pretreated for 2 h 
with or without 5 µM N-(3-aminopropyl)-2-[(3-methylphe-
nyl) methoxy]-N-(2-thienylmethyl)-benzamide hydrochlo-
ride (AMTB, Sigma-Aldrich), a specific TRPM8 inhibitor. 
Then, the cells were exposed to 2 mM DMSO or linalool for 
30 min, followed by rinse with HEPES buffer supplemented 
with 1 mM  Mn2+ and incubation with PE-conjugated anti-β1 
integrin antibody (clone HUTS-21; 1:20; BD Pharmingen, 
Heidelberg, Germany) at 37 °C for 30 min. After collection 
with a cell scraper, the cells were measured with a FACScan 
flow cytometer (BD Biosciences).
Migration assay
EC migration was analyzed by two different assays. For 
the scratch wound healing assay, 3.2 ×  105 HDMECs were 
seeded in 35-mm dishes and then exposed to different 
concentrations of linalool. After 24 h of incubation, four 
scratches were generated onto the cell monolayer using a 
10 µL pipette tip. Immediately after scratching (0 h) and 
after 6 h, images of the scratches were taken using a phase-
contrast microscope (Leica DFC450C;  Leica Microsystems, 
Wetzlar, Germany). Wound areas were measured using the 
LAS V4.8 software (Leica Microsystems).
For the transwell migration assay, HDMECs were seeded 
in 100-mm dishes and then exposed for 24 h to different 
concentrations of linalool. Thereafter, 2.5 ×  105 HDMECs 
treated with linalool or vehicle were suspended in 500 µL 
endothelial basal medium (EBM) without supplements and 
seeded into the inserts of 24-transwell plates (8 µm pores; 
Corning, Wiesbaden, Germany), while 750 µL EBM con-
taining 1% fetal calf serum (FCS) was added to the bottom 
chamber. After 5 h of incubation, the non-migrated cells 
were removed and the migrated cells were stained with 
Diff-Quick (LT-SYS, Berlin, Germany) and counted under 
a BZ-8000 microscope (Keyence, Osaka, Japan).
Tube formation assay
To assess the tube-forming activity of ECs, 1.7 ×  104 
HDMECs were seeded into each well of 96-well plates pre-
coated with 50 µL Matrigel (Corning) and then treated with 
different concentrations of linalool. After 24 h, the newly 
formed vessel-like structures were observed under a phase-
contrast microscope (BZ-8000; Keyence) and analyzed by 
quantifying the number of meshes using ImageJ software 
with the angiogenesis analyzer plug-in [U.S. National Insti-
tutes of Health (NIH), Bethesda, Maryland, USA].
Spheroid sprouting assay
As previously described [19], 500 HDMECs suspended in 
EGM-MV containing 20% methylcellulose (w/v) (Thermo 
Fisher Scientific) were seeded into each well of non-adherent 
round bottom 96-well plates. After 24 h of incubation, sphe-
roids were collected and suspended in a collagen solution 
mixed with EBM containing 20% FCS and 0.5% methylcel-
lulose (w/v) at a ratio of 1:2. This collagen solution consists 
of 8 volumes rat acidic collagen extract (Serva, Heidelberg, 
Germany), 1 volume 10 × Medium 199 (Sigma-Aldrich) 
and 1 volume 0.2 M NaOH. Then, the spheroid mixture was 
rapidly transferred into a pre-warmed 24-well plate. After 
incubation for 45 min, EGM-MV containing different con-
centrations of linalool was gently added onto the spheroids. 
The spheroids were photographed after 24 h of incubation 
by a phase-contrast microscope (Leica DFC450C) and the 
cumulative length of the sprouts that had grown out of each 
spheroid was measured using the LAS V4.8 software (Leica 
Microsystems).
Aortic ring assay
  As previously described [20], aortic rings from Wistar 
albino Glaxo rats were embedded in 200 µL Matrigel (Corn-
ing) in each well of 48-well plates. After incubation for 15 
min allowing for Matrigel polymerization, 800 µL Dulbec-
co’s modified Eagle’s medium (DMEM) containing 10% 
FCS, penicillin, streptomycin and different concentrations 
of linalool was added. After 6 days with a medium change 
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on day 3, the aortic rings were photographed by a phase-
contrast microscope (BZ-8000; Keyence) and the area of 
vascular sprouting from the aortic rings was measured using 
the image analysis application software (Keyence).
In vivo Matrigel plug assay
The in vivo effects of linalool on angiogenesis were evalu-
ated in a Matrigel plug assay. Briefly, 200 µL growth factor-
reduced Matrigel (Corning) containing 30 IU/mL heparin 
(Braun, Melsungen, Germany), 1 µg/mL VEGF (PAN Bio-
tech, Bayern, Germany) and 2 mM DMSO or linalool was 
injected subcutaneously into 5–7-month-old male BALB/c 
mice. After 7 days, the Matrigel plugs were excised for 
immunohistochemical analyses. This experiment was 
approved by the Local Animal Protection Committee and 
was conducted according to the German legislation for ani-
mal welfare and the Guide for the Care and Use of Labora-
tory Animals (8th Edition, 2011).
Immunohistochemistry
For the detection of microvessels within the Matrigel plugs, 
sections were cut and stained with a rat anti-mouse CD31 
antibody (1:100; Dianova, Hamburg, Germany) followed by 
a goat-anti-rat Alexa Fluor 555-labeled secondary antibody 
(1:100; Life Technologies). Cell nuclei were visualized by 
staining with Hoechst 33342 (Sigma-Aldrich). Sections were 
then analyzed using a fluorescence microscope (BZ-8000; 
Keyence) and the microvessel density was determined by 
counting the number of CD31-positive microvessels in 6 
microscopic regions of interest (ROIs) of each plug.
  Western blot analysis
Treated HDMECs were lysed with lysis buffer composed 
of 10 mM Tris (pH 7.5), 10 mM NaCl, 0.1 mM EDTA, 
0.5% Triton-X 100, 0.02%  NaN3, phenylmethylsulfonyl 
fluoride (1:500 v/v), protease inhibitor cocktail (1:100 
v/v; Sigma-Aldrich) and phosphatase inhibitor cocktail 
(1:100 v/v; Sigma-Aldrich) for 10 min on ice. The cell 
lysate was then transferred to tubes and centrifuged at 4 
°C for 30 min at 13,000 × g. The supernatant was col-
lected and protein concentrations were measured using 
the Pierce BCA Protein Assay (Thermo Fisher Scientific) 
with BSA as a standard. Subsequently, 10 µg proteins 
per lane were separated on 10% sodium dodecyl sulfate 
(SDS) polyacrylamide gels and transferred to a polyvi-
nylidene difluoride (PVDF) membrane (BioRad, Munich, 
Germany). The membrane was then blocked with Blot-
ting-Grade Blocker (BioRad) and incubated with a rabbit 
monoclonal anti-pAKT1/2/3 antibody (1:100; Cell Signal-
ing Technology), a rabbit monoclonal anti-AKT antibody 
(1:500; Cell Signaling Technology), a mouse monoclonal 
anti-pERK antibody (1:300; Abcam, Cambridge, UK), 
a rabbit polyclonal anti-ERK antibody (1:300; Abcam), 
a rabbit monoclonal anti-focal adhesion kinase (FAK) 
antibody (1:100; Cell Signaling Technology), a rabbit 
monoclonal anti-pFAK antibody (1:250; Cell Signaling 
Technology), a rabbit monoclonal anti-TRPM8 antibody 
(1:25; Abcam), a mouse monoclonal anti-bone morphoge-
netic protein (BMP)-2 antibody (1:30; Proteintech, Man-
chester, UK), a rabbit polyclonal anti-cyclin-dependent 
kinase (CDK)4 antibody (1:10; Santa Cruz Biotechnol-
ogy, Texas, USA), a rabbit polyclonal anti-CDK6 antibody 
(1:30; Santa Cruz Biotechnology), a rabbit monoclonal 
anti-CDK9 antibody (1:150; Cell Signaling Technology), 
a rabbit polyclonal anti-cyclooxygenase (COX)-2 antibody 
(1:50; Abcam), a mouse monoclonal anti-endothelial nitric 
oxide synthase (eNOS) antibody (1:100; BD Bioscience), 
a mouse monoclonal anti-intercellular adhesion molecule 
(ICAM)-1 antibody (1:30; Santa Cruz Biotechnology), a 
mouse monoclonal anti-p21 antibody (1:250; Abcam), a 
mouse monoclonal anti-Ras homolog family member A 
(RhoA) antibody (1:250; Cell Signalling Technology), a 
mouse monoclonal anti-sirtuin (SIRT)1 antibody (1:100; 
Abcam), a rabbit polyclonal anti-VEGFA antibody (1:50; 
Abcam) or a mouse monoclonal anti-β-actin antibody 
(1:5000; Sigma-Aldrich), followed by an anti-mouse 
(1:1500; Dako/Agilent, Hamburg, Germany) or anti-rabbit 
secondary antibody conjugated to horseradish peroxidase 
(HRP) (1:1000; R&D, Abingdon, UK). Protein signals 
were detected with an enhanced chemiluminescence (ECL) 
kit (GE Healthcare, Freiburg, Germany) under a Chem-
ocam device (Intas, Göttingen, Germany) and the band 
intensities were analyzed using ImageJ software (NIH).
Intracellular ATP measurement
The intracellular ATP level was measured using an ATP 
Determination Kit (Thermo Fisher Scientific) accord-
ing to the manufacturer’s instructions. Briefly, HDMECs 
were exposed to 2 mM DMSO or linalool in the pres-
ence or absence of 5 µM AMTB (Sigma-Aldrich) or 1 µM 
PD0325901, which specifically inhibits MEK/ERK signal-
ing (Selleckchem, Munich, Germany). After 24 h of incuba-
tion, the cells were rinsed with phosphate-buffered saline 
(PBS) and lysed with lysis buffer (Promega, Walldorf, Ger-
many) for 15 min at room temperature by shaking. The cell 
lysate was then centrifuged with full speed for 5 min. The 
supernatant was collected and mixed with standard reaction 
solution consisting of reaction buffer, 0.1 M DTT, 10 mM 
d-luciferin and firefly luciferase. Luminescence was meas-




Ca2+ transient acquisition and analysis
Ca2+ measurements in living ECs were conducted as previ-
ously described [21]. Briefly, 1 ×  105 HDMECs were seeded 
on a coverslip in each well of 12-well plates and treated 
for 2 h with 5 µM AMTB, 1 µM PD0325901 or 2.5 µM 
BAPTA-AM (Abcam), which is a specific  Ca2+ chelator. 
After loading with Fluo-4 AM (Life Technologies), cells 
were bathed in Tyrode’s solution (135 mM NaCl, 5.4 mM 
KCl, 1.8 mM  CaCl2, 10 mM glucose, 2 mM  MgCl2 and 10 
mM HEPES; pH 7.35) at 26 °C and mounted on an inverted 
microscope (Eclipse TE, Nikon, Düsseldorf, Germany) with 
20x oil-immersion objectives (Plan Fluor, 20 × 0.75, Nikon). 
Excitation was performed at the wavelength of 470 nm by 
LED (pE-100, CoolLED Ltd., Andover, USA) and the emis-
sion of Fluo-4 was detected by a COMS camera (Orca Flash 
4.0; Hamamatsu, Japan) with imaging at 5 frames per sec-
ond in a size of 512 × 512 pixels. Stimulation with chemical 
compounds at indicated concentrations was achieved by a 
local solenoid-controlled gravity-driven perfusion system. 
The acquired images were analyzed by ImageJ software to 
correct the image background and collect the fluorescence 
intensity in ROIs over time. The data were imported into 
IgorPro (Wavemetrics, Lake Oswego, USA) and processed 
as the self-ratio traces (F/F0), for which the fluorescence at 
any given time point (F) was divided by the resting fluores-
cence (F0) to account for different dye loading. The ampli-
tude of  Ca2+ transient was calculated as the peak value of 
the self-ratio trace.
Statistics
Statistical analysis was performed using the SigmaPlot 
software (SigmaStat; Jandel Corporation, San Rafael, CA, 
USA). Differences between two groups were analyzed by the 
unpaired Student’s t-test and differences between multiple 
groups were analyzed by one-way ANOVA followed by the 
Student–Newman–Keuls post hoc test including Bonferroni 
correction to compensate for multiple comparisons. All val-
ues were expressed as means ± SEM. Statistical significance 
was accepted for P-values < 0.05.
Results
Action of linalool on HDMEC viability 
and proliferation
We first investigated the effects of linalool on HDMEC via-
bility and cytotoxicity by means of WST-1 and LDH assays, 
respectively. These assays showed that linalool concentra-
tions of up to 2 mM do not affect the viability of HDMECs 
(Fig. 1a) and do not exert any cytotoxic effects on these cells 
(Fig. 1b). Accordingly, we chose non-cytotoxic concentra-
tions between 0.25 and 2 mM linalool for our in vitro and 
in vivo angiogenesis assays.
Next, we analyzed the effects of linalool on HDMEC 
proliferation. For this purpose, BrdU incorporated into cel-
lular DNA during cell proliferation was detected by flow 
cytometry. We found that 1 and 2 mM linalool causes a 15% 
and 23% reduction in HDMEC proliferation, respectively 
(Fig. 1c, d).
Action of linalool on HDMEC migration
To study the effects of linalool on the migratory activity of 
HDMECs, scratch wound healing and transwell migration 
assays were performed. Linalool significantly delayed the 
wound closure of scratched HDMEC monolayers (Fig. 2a, 
b) and dose-dependently reduced the number of migrated 
HDMECs (Fig. 2c, d).
Action of linalool on HDMEC tube formation 
and spheroid sprouting
We then analyzed the effects of linalool on the tube-forming 
capacity of HDMECs. Treatment with 2 mM linalool signifi-
cantly reduced the number of newly formed tube meshes in 
a tube formation assay (Fig. 3a, b).
Moreover, we demonstrated in a three-dimensional 
spheroid sprouting assay that linalool dose-dependently 
diminishes the cumulative length of sprouts growing out of 
HDMEC spheroids (Fig. 3c, d).
Action of linalool on angiogenesis ex vivo 
and in vivo
To confirm our in vitro findings, we performed an ex vivo 
aortic ring assay. In this assay, rat aortic rings embedded in 
Matrigel were incubated with different doses of linalool for 
6 days. By this, we observed that 1 and 2 mM linalool sig-
nificantly decreases the area of sprouting from aortic rings 
when compared to vehicle-treated controls (Fig. 4a, b).
In addition, we evaluated the effects of linalool on angio-
genesis in an in vivo Matrigel plug assay. Matrigel plugs 
containing 2 mM linalool exhibited a 31% lower microvessel 
density at day 7 after implantation into BALB/c mice when 
compared to controls (Fig. 4c, d).
Action of linalool on AKT and ERK signaling
To clarify the molecular mechanisms underlying the inhibi-
tory action of linalool on angiogenesis, we first analyzed 
the activity of two pivotal angiogenic signaling pathways, 
i.e., PI3K/AKT/mTOR and Raf/MEK/ERK, in HDMECs 
exposed to different concentrations of linalool. Western blot 
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analyses revealed that linalool strongly increases the phos-
phorylation of ERK without affecting AKT phosphoryla-
tion (Fig. 5a–c). Based on this result, we blocked the ERK 
pathway with PD0325901, a highly selective and non-ATP-
competitive MEK inhibitor. For this purpose, we used a con-
centration of 1 µM PD0325901, which was non-cytotoxic in 
a WST-1 assay (Fig. S1a), but reduced the linalool-increased 
as well as the basal level of phosphorylated ERK (Fig. 5d, 
e). Of interest, the inhibition of ERK phosphorylation mark-
edly counteracted linalool-suppressed HDMEC spheroid 
sprouting (Figs. 5f, S2a). To further confirm this finding, 
we downregulated the intracellular level of ERK by trans-
fecting HDMECs with siRNAs (si-ERK). The transfection 
efficiency of si-ERK was assessed by western blot and is 
shown in Fig. 5g, h. As expected, downregulation of ERK 
significantly suppressed the sprouting of HDMEC spheroids 
(Figs. 5i, S2b). However, ERK knockdown counteracted 
linalool-suppressed spheroid sprouting (Figs. 5i, S2b). This 
indicates that linalool inhibits angiogenesis at least partially 






















































































Fig. 1  Linalool inhibits HDMEC proliferation. a, b Viability (in % 
of 0 mM) of HDMECs (a) and cytotoxicity (in % of the total cell 
death) of linalool (b) as assessed by the WST-1 (a) and LDH assay 
(b), respectively. HDMECs were exposed for 24 h to serial dilutions 
(0.05–5 mM) of linalool or vehicle (0 mM) (n = 4). c: Flow cytometry 
scatter plots of HDMECs that were exposed for 24 h to 0.25, 1 and 
2 mM linalool or vehicle (0 mM), incorporated with BrdU and then 
stained with FITC-conjugated anti-BrdU antibody. d BrdU-positive 
cells (in % of the total cell number) of vehicle- or linalool-treated 
HDMECs (n = 3). Means ± SEM. *P < 0.05 vs. 0 mM
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Action of linalool on intracellular ROS levels
Recent studies showed that linalool induces ROS forma-
tion in several types of tumor cells, including glioblastoma 
U87 and hepatocellular carcinoma HepG2 cells [22, 23]. 
Uncontrolled ROS formation has been reported to impair the 
activity of ECs [24]. Indeed, plenty of chemical compounds, 
such as thalidomide, magnolol and dextran-catechin, exert 
their anti-angiogenic effects by triggering ROS production 
[25–27]. Therefore, we assessed the effects of linalool on the 
intracellular ROS levels of ECs. By flow cytometry follow-
ing DCFH-DA staining, we observed a significant increase 
of ROS production in linalool-treated HDMECs when com-
pared to vehicle-treated controls (Fig. 6a).  H2O2 was used as 
a positive control for ROS generation.
To further investigate whether ROS formation contrib-
utes to the inhibitory effect of linalool on angiogenesis, 
we utilized DTT, a wildly used reducing agent, to inhibit 
the production of ROS. For this purpose, linalool-exposed 
HDMEC spheroids were treated with a concentration of 0.5 
mM DTT, which was non-cytotoxic (Fig. S1c), but effec-
tively suppressed linalool- and  H2O2-induced ROS produc-
tion (Fig. 6a). However, our data showed that DTT has no 
effects on linalool-suppressed HDMEC sprouting (Figs. 6b, 
S3a).
Action of linalool on intracellular ATP levels
A previous study reported that linalool decreases intracel-
lular ATP levels and reduces the viability of HepG2 cells by 
inhibiting the mitochondrial complexes I and II [28]. Given 
the fact that ATP, the primary energy storage molecule, is 
essential for EC survival, proliferation and migration, we 
measured the intracellular ATP level of HDMECs by means 
of a luciferase assay. Treatment with 2 mM linalool sig-
nificantly reduced the intracellular ATP level by 28% when 
linalool (mM)
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Fig. 2  Linalool inhibits HDMEC migration. a Phase-contrast micro-
scopic images of HDMEC monolayers, which were scratched and 
then exposed for 6  h to 0.25, 1 and 2 mM linalool or vehicle (0 
mM). Wound areas are marked with white lines. Scale bar 220 µm. b 
Wound area (in % of 0 h) of scratched HDMEC monolayers at 0 and 
6 h, as assessed by the scratch wound healing assay (n = 8). c Light 
microscopic images of migrated HDMECs, which were treated for 
24 h with 0.25, 1 and 2 mM linalool or vehicle (0 mM). Scale bar 70 
µm. d Migration (in % of 0 mM) of HDMECs, which were treated 
with vehicle or linalool, as assessed by the transwell migration assay 
(n = 4). Means ± SEM. *P < 0.05 vs. 0 mM
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compared to vehicle-treated controls (Fig. 6c). Based on 
these findings, we added exogenous ATP to HDMEC sphe-
roids. This efficiently rescued the inhibition of HDMEC 
spheroid sprouting induced by linalool (Figs. 6d, S3b), indi-
cating that linalool inhibits angiogenesis at least partially 
through decreasing intracellular ATP levels.
Action of linalool on TRPM8 activity
Linalool was identified by Behrendt et al. as an agonist of 
TRPM8 [29]. This calcium-permeable cation channel has 
recently been shown to inhibit EC adhesion, migration and 
tube formation [8]. Therefore, we analyzed the activity of 
TRPM8 in linalool-treated HDMECs by measuring the 
intracellular calcium concentration. Menthol, a well-known 
TRPM8 agonist, highly stimulated the influx of  Ca2+ into 
HDMECs (Fig. 6e, f). Similarly, linalool markedly increased 
intracellular  Ca2+ concentrations (Fig. 6e, f). To further inves-
tigate whether linalool evokes  Ca2+ influx through activating 
TRPM8, we utilized the specific TRPM8 inhibitor AMTB. 
By means of a WST-1 assay, we observed that 10–100 µM 
AMTB significantly reduces HDMEC viability (Fig. S1b). 
Accordingly, we chose a non-cytotoxic concentration of 5 µM 
AMTB for the following assays. As expected, inhibition of 
TRPM8 with AMTB completely blocked the menthol-stim-
ulated  Ca2+ influx (Fig. 6e, f). Likewise, AMTB also totally 
reversed the increased intracellular  Ca2+ concentration in 
linalool-treated HDMECs (Fig. 6e, f), indicating that linalool 
activates TRPM8 in these cells.
To analyze whether activated TRPM8 mediates the anti-
angiogenic activity of linalool, the specific TRPM8 inhibi-
tor AMTB and siRNAs against TRPM8 (si-TRPM8) were 
exploited in the spheroid sprouting assays. The transfection 
efficiency of si-TRPM8 is evaluated in Fig. 6h, i. Consist-
ently, both TRPM8 inhibition and knockdown completely 
reversed linalool-reduced HDMEC spheroid sprouting 
(Figs. 6g, j, S3c, d), indicating that linalool downregulates 
angiogenesis at least in part through activating TRPM8.
Relation between ERK phosphorylation, 
intracellular ATP reduction and TRPM8 activation
The findings above demonstrate that linalool inhibits 
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Fig. 3  Linalool suppresses HDMEC tube formation and spheroid 
sprouting. a Phase-contrast microscopic images of tube-forming 
HDMECs. The cells were exposed for 18 h to 0.25, 1 and 2 mM lin-
alool or vehicle (0 mM). Scale bar 750 µm. b Tube formation (in % of 
0 mM) of HDMECs, which were treated with vehicle or linalool, as 
assessed by the tube formation assay (n = 4). c Phase-contrast micro-
scopic images of HDMEC spheroids, which were treated for 24  h 
with 0.25, 1 and 2 mM linalool or vehicle (0 mM). Scale bar 90 µm. d 
Sprouting (in % of 0 mM) of HDMEC spheroids, which were treated 
with vehicle or linalool, as assessed by the spheroid sprouting assay 
(n = 15). Means ± SEM. *P < 0.05 vs. 0 mM
Angiogenesis 
1 3
of ERK, reducing intracellular ATP levels and activating 
TRPM8. To determine the relation between these three 
mechanisms, we assessed the phosphorylation of ERK in 
HDMECs that were pretreated with AMTB or ATP and 
then exposed to linalool. Western blot analyses showed 
that the pretreatment with ATP, but not with AMTB, com-
pletely reversed linalool-induced ERK phosphorylation 
(Fig. 7a, b). This result suggests that the linalool-increased 
ERK phosphorylation is caused by the decreased intracel-
lular ATP levels, independently of TRPM8 activation.
Furthermore, we checked the intracellular ATP lev-
els of HDMECs treated with linalool alone or in com-
bination with AMTB or PD0325901. Luciferase assays 
showed that neither AMTB nor PD0325901 affects the 
reduction of intracellular ATP levels induced by linalool 
(Fig. 7c). These data confirm that intracellular ATP reduc-
tion locates upstream of ERK phosphorylation and also 
indicate that linalool-induced intracellular ATP reduction 
is independent of TRPM8 activation.
In addition, we assessed the activity of TRPM8 in 
HDMECs that were pretreated with PD0325901 and then 
exposed to linalool. Intracellular  Ca2+ measurements 
revealed that PD0325901 has no effect on linalool-stimu-
lated  Ca2+ influx (Fig. 7d, e). This demonstrates that linalool 
activates TRPM8 independently of ERK phosphorylation.
Downstream anti‐angiogenic mediators of linalool‐
induced ERK phosphorylation
It has been reported that phosphorylated ERK translocates 
into the nucleus and regulates hundreds of substrates, many 
of which participate in key physiological processes, such 
as cell proliferation, migration, survival and death [30]. To 
identify the downstream effectors of ERK that contribute 
to the anti-angiogenic effects of linalool, we analyzed the 
expression of 11 proteins, which are crucially involved in 
angiogenesis, in vehicle- and linalool-treated HDMECs 
by western blot. These proteins included BMP-2, CDK4, 
CD31/DAPI














































Fig. 4  Linalool inhibits angiogenesis ex  vivo and in  vivo. a Phase-
contrast microscopic images of rat aortic rings, which were embed-
ded in Matrigel and then exposed to 0.25, 1 and 2 mM linalool or 
vehicle (0 mM) for 6 days. Scale bar 750 µm. b Sprouting (in % of 
0 mM) of rat aortic rings, which were treated with vehicle or lin-
alool, as assessed by the aortic ring assay (n = 11). c Fluorescence 
microscopic images of sections from Matrigel plugs containing 0 
or 2 mM linalool. The sections were stained with anti-mouse CD31 
antibody (red) and Hoechst 33342 (blue) to visualize ECs and cell 
nuclei, respectively. Scale bar 45 µm. d Microvessel density (in % of 
0 mM) of Matrigel plugs containing 0 or 2 mM linalool, as assessed 
by immunohistochemistry (n = 9). Means ± SEM. *P < 0.05 vs. 0 mM
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Fig. 5  Linalool inhibits angiogenesis through activation of ERK. a 
Western blot of p-AKT, AKT, p-ERK, ERK and β-actin expression 
in HDMECs, which were exposed for 30 min to 0.25, 1 and 2 mM 
linalool or vehicle (0 mM). b, c Expression levels of pAKT/AKT 
(b) and pERK/ERK (c) (in % of 0 mM linalool) as assessed by west-
ern blot (n = 3  independent experiments). d Western blot of p-ERK, 
ERK and β-actin expression in HDMECs, which were pretreated for 
2 h with or without 1 µM PD0325901, a specific MEK inhibitor, and 
then exposed for 30 min to 0 or 2 mM linalool. e Expression levels 
of pERK/ERK (in % of 0 mM linalool) as assessed by western blot 
(n = 4 independent experiments). f Sprouting (in % of 0 mM linalool) 
of HDMEC spheroids, which were treated for 24 h with 0 or 2 mM 
linalool in the presence or absence of 1 µM PD0325901, as assessed 
by the spheroid sprouting assay (n = 10). g Western blot of ERK and 
β-actin expression in HDMECs, which were transfected for 48 h with 
20 nM si-NC or si-ERK. h Expression levels of ERK/β-actin (in % of 
si-NC) as assessed by western blot (n = 3  independent experiments). 
i Sprouting (in % of 0 mM linalool) of HDMEC spheroids consist-
ing of si-NC- or si-ERK-transfected cells, which were treated for 
24 h with 0 or 2 mM linalool, as assessed by the spheroid sprouting 
assay (n = 10). Means ± SEM. *P < 0.05 vs. 0 mM linalool or si-NC. 
#P < 0.05 vs. 2 mM linalool
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CDK6, CDK9, COX-2, eNOS, ICAM-1, p21, RhoA, SIRT1 
and VEGFA. Among them, the expression levels of eNOS 
and BMP-2 were significantly downregulated by linalool, 
while COX-2 was upregulated in linalool-treated HDMECs 
(Fig. S4a, b). To further determine whether linalool inhib-
its eNOS and BMP-2 expression through activating ERK, 
we examined the expression levels of the two proteins in 
HDMECs that were treated with vehicle or linalool in the 
presence or absence of PD0325901. Western blot analyses 
showed that the linalool-induced downregulation of BMP-
2, but not eNOS, is completely reversed by ERK inhibition 
(Fig. 8a–c). These findings indicate that linalool-induced 
ERK phosphorylation causes BMP-2 downregulation, which 
mediates the anti-angiogenic effect of linalool.
Downstream anti‐angiogenic mediators of linalool‐
induced TRPM8 activation
Our above findings showed that linalool induces TRPM8 
activation and consequently triggers  Ca2+ influx. To investi-
gate whether the anti-angiogenic effect of linalool is depend-
ent on TRPM8-mediated calcium signaling, the selective 
 Ca2+ chelator BAPTA-AM was used in the spheroid sprout-
ing assay. For this purpose, linalool-exposed HDMEC sphe-
roids were treated with a concentration of 2.5 µM BAPTA-
AM, which was non-cytotoxic (Fig. S1d), but completely 
inhibited linalool-induced  Ca2+ influx (Fig. 8d, e). By this, 
we could demonstrate that BAPTA-AM does not affect lin-
alool-suppressed spheroid sprouting (Fig. 8f). This indicates 
that linalool inhibits angiogenesis independently of the pore 
function of TRPM8.
Genova et al. reported that TRPM8 inhibits EC adhe-
sion through inactivation of β1 integrin/FAK signaling [8]. 
We therefore analyzed β1 integrin activity and FAK phos-
phorylation in HDMECs that were treated with vehicle or 
linalool in the presence or absence of AMTB by flow cytom-
etry and western blot, respectively. We found that treatment 
with linalool causes a 34% decrease in β1 integrin activity 
and a 30% reduction in FAK phosphorylation, which could 
be totally reversed by TRPM8 blockade (Fig. 8g–i). These 
findings indicate that linalool-induced TRPM8 activation 
inhibits β1 integrin/FAK signaling, which may explain the 
anti-angiogenic effect of linalool.
Discussion
Linalool is a naturally occurring monoterpene alcohol com-
monly found as a major component of essential oils from 
many aromatic plants. There are two enantiomers of lin-
alool, i.e., (3S)-(+)-linalool and (3R)-(−)-linalool, which 
differ in their distribution in plant species, fragrance and 
biological properties [31]. The subject of this study was 
(3R)-(−)-linalool, because this enantiomer is more com-
mon in nature [15]. Given the fact that in many studies the 
enantiomeric identity of linalool is not specified, we herein 
use the term ‘linalool’ for both enantiomers.
Linalool possesses a broad spectrum of biological activi-
ties. An increasing number of studies reported anticancer 
effects of this phytochemical in vitro and in vivo. This action 
of linalool has been mainly attributed to its anti-prolifera-
tive and cytotoxic effects on different types of tumor cells 
through the generation of oxidative stress, induction of cell 
cycle arrest and suppression of the epithelial-mesenchymal 
transition (EMT) process [32–36]. In contrast, the effects of 
linalool on angiogenesis, which is essential for tumor growth 
and metastasis, remain elusive. In the present study, we now 
demonstrate a potent inhibitory effect of linalool on the angi-
ogenic activity of ECs, which may markedly contribute to 
the anticancer activity of the compound.
Angiogenesis is a complex multi-step process, which 
includes EC proliferation, migration and tube formation 
[37]. To investigate which steps of this process are affected 
by linalool treatment, we performed a panel of in vitro angi-
ogenesis assays. We found that linalool exerts pleiotropic 
anti-angiogenic effects on HDMECs, including the inhibi-
tion of HDMEC proliferation, migration, tube formation 
and spheroid sprouting. For this purpose, we used rather 
high linalool doses of 1 and 2 mM, which, however, did not 
affect the viability of the cells. In this context, it should be 
considered that linalool exhibits a poor solubility in culture 
medium and a low in vivo bioavailability. Accordingly, we 
used DMSO to increase the solubility of the compound in 
our in vitro assays.
In a next step, we investigated the effects of linalool 
on angiogenesis in an ex vivo rat aortic ring assay, which 
is based on the capacity of aortic rings to form new ves-
sels in Matrigel, allowing the analysis of EC proliferation, 
migration, tube formation, microvessel branching and 
maturation [38]. Importantly, this assay closely mimics an 
in vivo environment. In fact, the angiogenic sprouting from 
aortic rings occurs in the presence of smooth muscle cells, 
pericytes, macrophages and fibroblasts [38]. In addition, 
the native ECs of aortic rings have not been modified by 
repeated passages and are quiescent at the time of explanta-
tion [39]. Accordingly, the aortic ring assay is widely used 
to evaluate the efficiency of pro- and anti-angiogenic com-
pounds. In line with our HDMEC culture experiments, lin-
alool significantly suppressed the vascular sprouting from 
rat aortic rings. Moreover, we found that linalool signifi-
cantly reduces the microvessel density of Matrigel plugs 7 
days after implantation into BALB/c mice when compared 
to controls. Notably, in this assay we analyzed the density 
of CD31-positive microvessels by means of immunohisto-
chemistry. This parameter is more accurate compared to the 
measurement of plasma volume and hemoglobin mass in 
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plugs, which crucially depends on the plug size [40]. Taken 
together, our findings demonstrate that linalool exhibits a 
potent anti-angiogenic activity, which is reproducible in 
several experimental in vitro and in vivo settings using ECs 
of different species.
To gain further insights into the mechanisms underly-























































































































































































































































effects of the compound on two key angiogenesis-related 
signaling pathways, i.e., PI3K/AKT/mTOR and Raf/MEK/
ERK. In contrast to previous studies reporting that linalool 
inhibits AKT/mTOR signaling in human oral cancer OECM 
1 cells and hepatoma HepG2 cells [23, 41], we did not detect 
a suppression of AKT phosphorylation in linalool-treated 
HDMECs. This indicates that the compound acts via differ-
ent mechanisms in malignant tumor cells and benign ECs. 
Of interest, we observed that linalool markedly increases the 
phosphorylation of ERK and inhibition of MEK/ERK sign-
aling by PD0325901 largely reverses linalool-suppressed 
spheroid sprouting. This is an unexpected finding consider-
ing the fact that ERK signaling is widely accepted to pro-
mote EC survival and angiogenesis [42], although there are 
several studies indicating that ERK activation induces cell 
cycle arrest and apoptosis [5, 7].
Furthermore, we showed that linalool-induced intra-
cellular ATP reduction and TRPM8 activation, but not 
ROS formation, contribute to the anti-angiogenic effect 
of linalool. Of interest, the intracellular ATP reduction 
promoted ERK phosphorylation. This view is supported 
by our results that (i) ATP supplementation completely 
reverses linalool-increased phosphorylated ERK and (ii) 
the inhibition of ERK phosphorylation has no effects on 
the reduction of intracellular ATP. In contrast, previous 
studies reported that extracellular ATP stimulates ERK 
signaling in several types of cells [43–45] and ATP deple-
tion induced by anoxia reduces ERK phosphorylation 
[46]. These contradictory findings suggest a complex 
regulatory mechanism of ERK activation dependent on 
the intracellular level of ATP. As observed in our study, a 
slight intracellular ATP reduction may serve as a stimulus 
for the activation of ERK. On the other hand, the phos-
phorylation of ERK may not be possible under complete 
ATP deprivation due to the lack of the phosphate donor. 
The precise mechanism of how a slight intracellular ATP 
reduction causes ERK phosphorylation needs to be further 
elucidated. However, it is already known that the inhibi-
tors of mitochondrial complex I rotenone and metformin, 
which reduce intracellular ATP levels, enhance ERK phos-
phorylation by promoting the dimerization of the kinase 
suppressor of Ras (KSR) with Raf, which catalyzes MEK 
phosphorylation [47]. Since linalool is also a mitochon-
drial complex I inhibitor [28], we therefore assume that 
it may induce ERK phosphorylation through regulating 
KSR-Raf dimerization.
In addition, we found that TRPM8 blockade has no 
influence on linalool-triggered ATP reduction and ERK 
phosphorylation. Moreover, ERK inhibition did not affect 
TRPM8 activity in linalool-treated HDMECs. These results 
demonstrate that linalool-induced TRPM8 activation is inde-
pendent on intracellular ATP reduction and ERK phospho-
rylation. This view is further supported by our observation 
that linalool activates TRPM8 within seconds, while the 
linalool-induced phosphorylation of ERK requires a longer 
time span.
Finally, we investigated the mechanism of how linalool-
induced ERK phosphorylation inhibits angiogenesis. By 
performing a western blot-based small-scale expression 
screening of angiogenesis-regulatory proteins, we found 
that BMP-2  is downregulated by linalool-induced ERK 
phosphorylation. BMP-2 is a member of the transforming 
growth factor (TGF) superfamily. It has been reported to 
promote proliferation, migration and tube formation of sev-
eral types of ECs [48–50]. In vivo, BMP-2 enhances angio-
genesis in the mouse sponge assay and stimulates neovas-
cularization in tumors formed from A549 and MCF-7 cells 
[48, 49]. Notably, several studies demonstrated that BMP-2 
acts upstream of ERK [48, 51, 52]. On the other hand, it 
is well known that phosphorylated ERK translocates into 
the nucleus, where it regulates different transcription fac-
tors [30]. Therefore, it is reasonable that BMP-2 can also 
be influenced by linalool-induced ERK phosphorylation. 
In fact, previous studies have already shown that different 
compounds, including wedelolactone [53], fucoidan [54], 
imperatorin and bergapten [55], induce ERK phosphoryla-
tion in human mesenchymal stem cells or osteoblasts, which, 
in turn, regulates BMP-2 expression. Accordingly, it may be 
assumed that the herein observed BMP-2 downregulation 
Fig. 6  Linalool inhibits angiogenesis through reducing intracellu-
lar ATP and activating TRPM8. a DCFH fluorescence (in fold of 0 
mM linalool) in HDMECs, which were pretreated with or without 0.5 
mM DTT, a reducing agent, and then exposed to 0 or 2 mM linalool 
for 24 h or 0.5 mM  H2O2 for 30 min, as assessed by flow cytometry 
(n = 3 independent experiments). b Sprouting (in % of 0 mM linalool) 
of HDMEC spheroids, which were treated for 24 h with 0 or 2 mM 
linalool in the presence or absence of 0.5 mM DTT, as assessed by 
the spheroid sprouting assay (n = 10). c Intracellular ATP level (in % 
of 0 mM) of HDMECs, which were treated for 24 h with 0 or 2 mM 
linalool, as assessed by the luciferase assay (n = 4). d Sprouting (in 
% of 0 mM linalool) of HDMEC spheroids, which were treated for 
24  h with 0 or 2 mM linalool in the presence or absence of 1 mM 
ATP, as assessed by the spheroid sprouting assay (n = 10). e  Ca2+ 
signal (F/F0) in HDMECs, which were pretreated with or without 5 
µM AMTB (a specific TRPM8 blocker) for 2 h, loaded with Fluo-4 
AM and then stimulated with 0 or 2 mM linalool or 1 mM menthol. 
The onset of stimulation is indicated by a black arrow. f Peak ampli-
tude (F/F0) of  Ca2+ signal in HDMECs, which were pretreated with 
or without AMTB, loaded with Fluo-4 AM and then stimulated with 
vehicle, linalool or menthol. g Sprouting (in % of 0 mM linalool) 
of HDMEC spheroids, which were treated for 24 h with 0 or 2 mM 
linalool in the presence or absence of 5 µM AMTB, as assessed by 
the spheroid sprouting assay (n = 10). h Western blot of TRPM8 and 
β-actin expression in HDMECs, which were transfected for 48 h with 
120 nM si-NC or si-TRPM8. i Expression levels of TRPM8/β-actin 
(in % of si-NC) as assessed by western blot (n = 3 independent experi-
ments). j Sprouting (in % of 0 mM linalool) of HDMEC spheroids 
consisting of si-NC- or si-TRPM8-transfected cells, which were 
treated for 24 h with 0 or 2 mM linalool, as assessed by the spheroid 
sprouting assay (n = 10). Means ± SEM. *P < 0.05 vs. 0 mM linalool 




is induced by linalool-promoted ERK phosphorylation, and 
that this mediates the anti-angiogenic effect of linalool. We 
also demonstrated that the activation of TRPM8 channels 
triggered by linalool blocks β1 integrin/FAK signaling. 
These results confirm the observation of Genova et al. that 
TRPM8 inhibits EC migration via a non-channel function 
by trapping Rap1 intracellularly and consequently impairing 
integrin activation [8]. Hence, this ion channel is a promis-
ing novel target for anti-angiogenic therapy.
In summary, the present study demonstrates for the first 
time that linalool acts as an angiogenesis inhibitor by tar-
geting multiple independent angiogenesis-related media-
tors (Fig. 9). This could be a major advantage of linalool 
compared to highly selective anti-angiogenic agents, because 
this pleiotropic action profile may prevent cellular escape 
mechanisms. Accordingly, linalool may represent a promis-
ing therapeutic agent or a lead compound for the future treat-
ment of angiogenesis-related diseases. However, it should be 
considered that, like other phytochemicals, linalool exhibits 
a low in vivo bioavailability. Hence, it will be necessary to 
develop sophisticated carrier systems and novel derivatives 
or prodrugs to improve the pharmacokinetic properties of 
the compound. Rapid progress in modern drug design and 
nanotechnology may markedly contribute to achieve this in 
the future.
Fig. 7  Supplementation of ATP reverses linalool-induced ERK phos-
phorylation independently of TRPM8 activation. a Western blot 
of p-ERK, ERK and β-actin expression in HDMECs, which were 
pretreated for 2 h with or without 5 µM AMTB or 1 mM ATP and 
then exposed for 30 min to 0 or 2 mM linalool. b Expression lev-
els of pERK/ERK (in % of 0 mM linalool) as assessed by western 
blot (n = 3  independent experiments). c Intracellular ATP level (in 
% of 0 mM linalool) of HDMECs, which were treated with 0 or 2 
mM linalool in the presence or absence of 5 µM AMTB or 1 µM 
PD0325901, as assessed by the luciferase assay (n = 4). d  Ca2+ signal 
(F/F0) in HDMECs, which were pretreated for 2  h with or without 
1 µM PD0325901, loaded with Fluo-4 AM and then stimulated with 
0 or 2 mM linalool. The onset of stimulation is indicated by a black 
arrow. e Peak amplitude (F/F0) of  Ca2+ signal in HDMECs, which 
were pretreated with or without PD0325901, loaded with Fluo-4 AM 
and then stimulated with vehicle or linalool. Means ± SEM. *P < 0.05 
vs. 0 mM linalool. #P < 0.05 vs. 2 mM linalool
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Fig. 8  Linalool downregulates BMP-2 by phosphorylating ERK and 
inhibits β1 integrin/FAK signaling by activating TRPM8. a Western 
blot of eNOS, BMP-2 and β-actin expression in HDMECs, which 
were pretreated for 2 h with or without 1 µM PD0325901 and then 
exposed for 30 min to 0 or 2 mM linalool. b, c Expression levels of 
eNOS/β-actin (b) and BMP-2/β-actin (c) (in % of 0 mM linalool) as 
assessed by western blot (n = 4  independent experiments). d  Ca2+ 
signal (F/F0) in HDMECs, which were pretreated with or without 
2.5 µM BAPTA-AM (a selective  Ca2+ chelator) for 2 h, loaded with 
Fluo-4 AM and then stimulated with 0 or 2 mM linalool. The onset 
of stimulation is indicated by a black arrow. e Peak amplitude (F/F0) 
of  Ca2+ signal in HDMECs, which were pretreated with or with-
out BAPTA-AM, loaded with Fluo-4 AM and then stimulated with 
vehicle or linalool. f Sprouting (in % of 0 mM linalool) of HDMEC 
spheroids, which were treated for 24  h with 0 or 2 mM linalool in 
the presence or absence of 2.5 µM BAPTA-AM, as assessed by the 
spheroid sprouting assay (n = 10). g Active β1 integrin (in % of 0 mM 
linalool) in HDMECs, which were pretreated for 2 h with or without 
5 µM AMTB and then exposed for 30 min to 0 or 2 mM linalool, as 
assessed by flow cytometry (n = 3). h Western blot of p-FAK, FAK 
and β-actin expression in HDMECs, which were pretreated for 2  h 
with or without 5 µM AMTB and then exposed for 30 min to 0 or 2 
mM linalool. i Expression levels of pFAK/FAK (in % of 0 mM lin-
alool) as assessed by western blot (n = 4  independent experiments). 
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